Clinical Trials Logo

Clinical Trial Summary

This is a multi-center, open-label, 6-month study to evaluate the safety of bilateral CNTF implants in participants with Macular Telangiectasia Type 2.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04729972
Study type Interventional
Source Neurotech Pharmaceuticals
Contact
Status Completed
Phase Phase 2
Start date August 13, 2021
Completion date December 23, 2022

See also
  Status Clinical Trial Phase
Completed NCT03316300 - A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A Phase 3
Completed NCT03319849 - A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 Phase 3
Active, not recruiting NCT04907084 - Serine and Fenofibrate Study in Patients With MacTel Type 2 Phase 2
Completed NCT01949324 - A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel Phase 2
Not yet recruiting NCT06397131 - A Study to Determine the Safety and Efficacy of NT-501 With MHFM Phase 3